Perdagangan Gilead GILD

Gilead diagram langsung

Dasar-dasar Instrumen

Weekly Search
Weekly
Daily
Tanggal Tutup Ubah Ubah (%) Buka Tinggi Rendah

Berita Terkini

Tommy Yap 2025 Apr 16, 16:00

Morning Note: UK Inflation Data, US Retail Sales Loom, BoC Rate Expected to Hold

Morning Note USD CAD GBP
Tommy Yap 2025 Apr 16, 16:00

Morning Note: TSMC Booms Amid Trade Concerns; ECB Set to Ease; Aussie Jobs Recover

Morning Note AUD USD
Frances Wang 2025 Apr 16, 16:00

Stock market today: Dow drops, Nasdaq tumbles, S&P 500 sinks

Indices
Frances Wang 2025 Apr 15, 16:00

Crude oil price today: How much is crude oil per barrel today?

Commodities
Frances Wang 2025 Apr 15, 16:00

Stock market index: Russell 2000 Index Swings Amid Tariff Fears

Indices
Tommy Yap 2025 Apr 14, 16:00

Morning Note: Oil Rises on Tariff Relief Hint; UK Jobs in Focus; Canada CPI Looms

Morning Note Commodities
Frances Wang 2025 Apr 13, 16:00

Bitcoin price today: what’s going on with Solana, XRP, and Dogecoin?

Cryptocurrencies
Frances Wang 2025 Apr 13, 16:00

Stock Market Today: Dow, S&P 500, and Nasdaq Futures Start Off Stronger

Indices Stocks

Info

Spread

0.65

Spread (%)

0.6215 %

Leverage

1:10

Bunga Overnight Beli

-0.0597 %

Bunga Overnight Jual

-0.0292 %

Mata Uang

USD

Jam Trading

Pasar tutup

Kamis

13:31 - 19:59

Senin

13:31-19:59

Selasa

13:31-19:59

Rabu

13:31-19:59

Analisis dan Statistik

Buka

---

Sebelumnya Tutup

---

52 Minggu Tigg/Rdh

--- – ---

Kapitalisasi Pasar

131743858688

Saham yang Beredar

1246630016

Tanggal Penghasilan (Berikutnya)

2013-01-28

Hasil Div

2025-03-28

Tanggal Non-Dividen

2025-03-14

Proyeksi tingkat dividen tahunan

3.16

Proyeksi hasil dividen tahunan

0.0297

EPS

0.38

Pelajari lebih lanjut tentang instrumen ini

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.
Trustpilot